GRP
RYTM icon

Global Retirement Partners’s Rhythm Pharmaceuticals RYTM Stock Holding History

Global Retirement Partners’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.1K Buy
+460
New +$41.6K ﹤0.01% 2506
2025
Q4 		$91.7K Buy
857
+457
+114% +$48.5K ﹤0.01% 1964
2025
Q3 		$40.4K Hold
400
– – ﹤0.01% 2024
2025
Q2 		$25.3K Buy
+400
New +$24.5K ﹤0.01% 2155
2024
Q4 		– Sell
-35
Closed -$1.83K – 3765
2024
Q3 		$1.83K Hold
35
– – ﹤0.01% 2966
2024
Q2 		$1.44K Hold
35
– – ﹤0.01% 3068
2024
Q1 		$1.52K Hold
35
– – ﹤0.01% 2847
2023
Q4 		$1.42K Buy
35
+7
+25% +$221 ﹤0.01% 2791
2023
Q3 		$599 Buy
+28
New +$627 ﹤0.01% 2908

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Global Retirement Partners's RYTM Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Rhythm Pharmaceuticals (RYTM) in Q2 2026: 460 shares worth $51.1K. The stake represents ﹤0.01% of the portfolio and ranks #2506 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in RYTM as recently as Q4 2025.

Global Retirement Partners first reported a position in RYTM in Q3 2023 and has held it in 9 quarters since. The position peaked at $91.7K in Q4 2025. 305 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Global Retirement Partners held 460 shares of Rhythm Pharmaceuticals worth $51.1K as of Q2 2026.
  • Rhythm Pharmaceuticals was a new Global Retirement Partners position in Q2 2026.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #2506 holding.
  • Global Retirement Partners first reported a position in Rhythm Pharmaceuticals in Q3 2023 and has held it in 9 quarters since.
  • Global Retirement Partners's Rhythm Pharmaceuticals position peaked at $91.7K in Q4 2025.
  • 305 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.